文献速递乳腺癌

转录组测定肿瘤浸润淋巴细胞在局限性乳腺癌中的预后价值

Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer.
PubMed 文献 · Eur J Cancer · 2019-09-06

本研究利用1928份纯细胞转录组数据构建淋巴细胞、髓系细胞、基质细胞和癌细胞特异性基因标签,计算RNA TIL评分,并在两个公开数据集(CIT n=530;Metabric n=1832)的辅助治疗患者中验证其与组织学TIL及预后的关联。高RNA TIL评分与组织学高TIL水平显著相关,且在多变量Cox模型中与DFS和OS相关,但该预后关联仅在基底样肿瘤中显著。结论认为转录组标签评估TIL率可行,在辅助治疗的基底样肿瘤患者中具有高预后价值。

要点

  • 转录组RNA TIL评分与组织学高TIL水平显著相关
  • RNA TIL评分在基底样肿瘤中与生存显著相关
  • 该评分在多变量模型中与DFS和OS相关

核心结论

  • 转录组标签评估TIL率可行,在辅助治疗的基底样肿瘤患者中具有高预后价值。

研究设计与样本

  • 利用1928份纯细胞转录组图谱生成淋巴细胞、髓系细胞、基质细胞和癌细胞特异性基因标签。
  • 基于该标签计算RNA TIL评分,并在两个公开数据集CIT(n=530)和Metabric(n=1832)的辅助治疗患者中验证。

主要发现

  • 高RNA TIL评分与组织学评估的高TIL水平显著相关。
  • 在单变量分析中,RNA TIL评分仅在基底样肿瘤中与生存相关。

临床怎么用

  • RNA TIL评分可作为组织学TIL检测的补充工具,用于评估局限性乳腺癌辅助治疗患者的预后。
  • 在基底样肿瘤患者中,RNA TIL评分可能有助于识别预后较好的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tumour-infiltrating lymphocyte (TIL) detection by histology is associated with outcomes in breast cancer; nevertheless, analysis standardisation is difficult. We determined whether transcriptomic data could generate a genomic signature that estimated TIL infiltrates and determined patient prognosis in localised breast cancer. EXPERIMENTAL DESIGN: Using 1928 transcriptomic profiles of pure cells, we generated a genetic signature specific to lymphocyte, myeloid, stromal and cancer cells. We then computed a score based on this signature and tested the association between the score and the TILs estimated for patients in an adjuvant setting from public and private data sets. We tested the capacity of the transcriptomic RNA TIL score to predict disease-free survival (DFS) or overall survival (OS) through multivariate Cox models adjusted for classical clinical variables and PAM50 molecular classification in two public data sets (Carte d'Identité des Tumeurs [CIT], n = 530; Metabric, n = 1832). RESULTS: A high RNA TIL score was significantly associated with the presence of a high level of TILs as assessed by histology. The score was also associated with DFS and OS in multivariate Cox models adjusted for molecular and clinical variables (CIT: OS hazard ratio [HR] = 0.15 [0.04, 0.61], p-value = 0.007; DFS: 0.27 [0.08, 0.8] p-value = 0.02; Metabric: OS HR = 0.87 [0.77, 0.97], p-value = 0.01). The association between the RNA TIL score and survival was tested by univariate analysis in each molecular subgroup; the RNA TIL score was associated with survival only in basal-like tumours. CONCLUSIONS: Determination of the TIL rate using a transcriptomic signature is feasible and has a high prognostic value in patients with basal-like tumours in an adjuvant setting.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Truntzer C, Isambert N, Arnould L, et al. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer. Eur J Cancer. 2019. PMID: 31499385. doi:10.1016/j.ejca.2019.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。